Detalles de la búsqueda
1.
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.
Biol Blood Marrow Transplant
; 26(6): 1210-1217, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32088366
2.
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.
Blood
; 132(25): 2639-2642, 2018 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30266774
3.
Safety Analysis of Brentuximab Vedotin from the Phase III AETHERA Trial in Hodgkin Lymphoma in the Post-Transplant Consolidation Setting.
Biol Blood Marrow Transplant
; 24(11): 2354-2359, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29859255
4.
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.
Lancet
; 389(10068): 519-527, 2017 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28017406
5.
Calcineurin and mTOR Inhibitor-Free Post-Transplantation Cyclophosphamide and Bortezomib Combination for Graft-versus-Host Disease Prevention after Peripheral Blood Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I/II Study.
Biol Blood Marrow Transplant
; 23(10): 1651-1657, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28549771
6.
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant
; 23(2): 269-277, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27864161
7.
Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis.
Cancer
; 123(8): 1416-1423, 2017 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27893933
8.
Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity.
Biol Blood Marrow Transplant
; 22(5): 869-78, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26827660
9.
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial.
Biol Blood Marrow Transplant
; 22(12): 2256-2263, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27565521
10.
Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.
Biol Blood Marrow Transplant
; 22(10): 1893-1899, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27496215
11.
Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.
Biol Blood Marrow Transplant
; 22(3): 520-7, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26597080
12.
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Cancer
; 122(1): 91-8, 2016 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26439325
13.
Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma.
Br J Haematol
; 175(5): 860-867, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27649689
14.
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 385(9980): 1853-62, 2015 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25796459
15.
Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
Biol Blood Marrow Transplant
; 21(1): 159-64, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25445637
16.
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma.
Biol Blood Marrow Transplant
; 21(2): 335-41, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25445028
17.
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 21(7): 1155-66, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25769794
18.
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.
Biol Blood Marrow Transplant
; 21(10): 1830-8, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26116089
19.
High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients.
Biol Blood Marrow Transplant
; 20(7): 979-85, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24709007
20.
Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902.
Biol Blood Marrow Transplant
; 20(10): 1530-6, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24910380